Metraipolis › archive › dc_ea34e0bf2de2

Anti-B Cell Strategy in Nephrotic Syndrome: Beyond Rituximab — Europe PMC PMID:41007627

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41007627
DOI: 10.3390/biomedicines13092063
License (as archived): solo-consultazione
Archived: 2026-11-10T09:51:06.934Z
SHA-256 of the archived text: e2de3d3b3ded654fe4e78d911a83b3e12f77a1f1d2d204216ca7c504ab2f10ef
Stable URL of this page: https://metraipolis.com/documento/dc_ea34e0bf2de2

How to cite

Anti-B Cell Strategy in Nephrotic Syndrome: Beyond Rituximab — Europe PMC PMID:41007627 — Europe PMC (en), https://europepmc.org/article/MED/41007627 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ea34e0bf2de2 (Metraipolis archive dc_ea34e0bf2de2, sha256 e2de3d3b3ded654fe4e78d911a83b3e12f77a1f1d2d204216ca7c504ab2f10ef)

BibTeX

@misc{dcea34e0bf2de2,
  title = {Anti-B Cell Strategy in Nephrotic Syndrome: Beyond Rituximab — Europe PMC PMID:41007627},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41007627},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ea34e0bf2de2; sha256 e2de3d3b3ded654fe4e78d911a83b3e12f77a1f1d2d204216ca7c504ab2f10ef},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41007627. Agents can read the archived copy with the MCP tool read_document.